Stay updated on Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Sign up to get notified when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.

Latest updates to the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3 from the record history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry, Revision: v3.4.2, was added to the history. The operating-status notice and the previous revision entry, v3.4.1, were removed from the page.SummaryDifference0.5%

- Check61 days agoChange DetectedAdded a site-wide notice about government funding and the NIH Clinical Center's operating status. Updated the record to Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.5%

- Check68 days agoChange DetectedThe history page now includes a glossary display option, color-coded diffs showing additions in green and deletions in red, and visible revision notes (e.g., Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check104 days agoChange DetectedIn the page footer, Revision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tamibarotene Plus Azacitidine in RARA+ MDS Clinical Trial page.